Skip to content

BIO FRONTIER

  • Home
  • Artificial intelligence
  • Biotechnology
  • Genetics
  • Medical Technology
    • Home
    • Uncategorized
    • GSK to buy RAPT Therapeutics in deal valued at $2.2B

GSK to buy RAPT Therapeutics in deal valued at $2.2B

Jan 20, 2026

Post navigation

Alteogen Announces Exclusive License Agreement with Tesaro, a Subsidiary of GSK, for the Development of a Subcutaneous Formulation of Dostarlimab Enabled by Hybrozyme™ Technology
Bristol Myers Squibb taps Microsoft’s AI detection network for speedy lung cancer diagnosis
  • PR Newswire
  • GlobeNewswire
  • Contact
  • Privacy Policy

BIO FRONTIER

Header Toggle Sidebar

This is an example widget to show how the Header Toggle Sidebar looks by default. You can add custom widgets from the widgets in the admin.